BD

Every second, 80 patients worldwide receive care with a syringe made by BD.  Invented at our Canaan site in 1961, the BD® Syringe supports global patient care, from routine vaccines to critical procedures — and now it’s in the running for CBIA’s 2026 "Coolest Thing Made in Connecticut." (Voting begins Aug. 20.)   Watch as Ahmad Warraich, plant manager, and Zane VanWagoner, senior operations manager, take us inside our Canaan, Connecticut site, where our dedicated BD associates manufacture more than 2 billion syringes each year. #MadeInConnecticut #USManufacturing #HealthcareSupplyChain 

Enrollment is now completed in the PREVENT clinical trial. https://lnkd.in/eTA_46V5 The study enrolled 477 patients across 32 sites and is evaluating Phasix™ Mesh for the prevention of incisional hernia. This milestone reflects our commitment to advancing clinical evidence and helping shape the future of hernia care.  

Bringing a child into the world should be one of life's most joyful moments. Yet for too many women, complications during childbirth can quickly become life-threatening. As cesarean births continue to rise globally, there is growing focus on the importance of earlier detection and more proactive management of hemodynamic instability during cesarean delivery. In a new blog, Tim Patz, worldwide president of BD Advanced Patient Monitoring, explores a critical gap in maternal care and highlights key findings from BD's recent white paper, "A Call to Action: The Need for Enhanced Maternal Hemodynamic Monitoring in Cesarean Birth."

Momentum continues to build at BD. In a recent conversation with CNBC's Mad Money, Chairman, CEO and President Tom Polen discussed our Q3 performance and the progress we're making as the New BD. Our first full quarter as a more focused organization highlights the impact of strong execution, disciplined continuous improvement through BD Excellence and a portfolio aligned to where we can create the greatest value. As we build on this momentum, we're positioning BD to make an even greater impact for customers, clinicians and patients around the world. Watch the conversation with Jim Cramer below.

What if healthcare teams could identify a negative clinical trajectory in a patient before traditional symptoms appear? According to Bilal Muhsin EVP and President of BD's Connected Care Segment, continuous data is key. https://lnkd.in/etHRJkCc In this interview, part of Newsweek's Investment Reports’ “Hospitals Reimagined” series, Muhsin explains how by moving beyond intermittent snapshots and enabling continuous, real-time insights, connected care can help clinicians act earlier and make more informed decisions. Read more about how BD is helping advance the future of connected care to give hospitals a more complete view of the care continuum. #medtech #ConnectedCare

BD Reports Third Quarter Fiscal 2026 Financial Results: https://lnkd.in/eQsfg8iW. Review forward looking statement: https://lnkd.in/e4bj-aw2. #BDXEarnings

Advancing continuous monitoring, one beat at a time. Providing clinicians with accurate, continuous patient data is essential to informed treatment decisions. In this interview with Medical Design & Outsourcing, Tim Patz, President, BD Advanced Patient Monitoring, discusses the innovation behind the HemoSphere™ Stream Module and his vision for advancing noninvasive continuous monitoring, helping clinicians access real-time patient insights from admission through discharge. https://lnkd.in/eruwcb_f

This National Intern Day, we're celebrating our interns for the energy, ideas and fresh perspectives they're bringing to teams across BD. Their curiosity embodies the mindset that fuels continuous improvement and helps us keep raising the bar for customers and patients. Today, the group spanning across 16 BD locations came together for a live Q&A with Chief People Officer Manish Sinha, gaining insights on career opportunities, leadership and the future of BD. Through hands-on work and experiences like these, they're seeing firsthand how BD is accelerating innovation, delivering for customers and making a meaningful difference for patients around the world. We're proud of the impact they've already made and grateful to the associates supporting them along the way. Interested in joining a future cohort? Learn more about our early talent programs here: https://bit.ly/4xQc4Ic #ProudtoBeBD #NationalInternDay

EMS and BD expand access to GLP-1 therapies in Brazil with semaglutide launch: https://bit.ly/4h3RMFo Collaboration pairs leadership in pharmaceuticals and advanced drug delivery technology to support a consistent, reliable treatment experience for metabolic disease patients. #GLP1 #drugdelivery #medtech #pharmaceuticalsystems

We may think of blood tests as routine, but Jessica Fox, VP of HR for BD - Specimen Management, and her family will never skip a blood test. While preparing for their first child, her husband Brady experienced sudden health issues that could have jeopardized the life they had envisioned together. But a blood test gave them answers they needed when it mattered most. Learn more: https://lnkd.in/exNSSTzC